Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Sales | 728 | 1,884 | 1,884 | 1,259 | 1,258 |
| Gross Profit | 728 | 1,884 | 1,884 | 1,259 | 1,258 |
| Operating Expenses | 7,914 | 6,277 | 10,387 | 11,160 | 9,399 |
| Operating Income | -7,186 | -4,393 | -8,503 | -9,901 | -8,141 |
| Interest Expense | 380 | 433 | 486 | 529 | 572 |
| Other Income | 609 | 999 | -704 | -2,987 | -293 |
| Pre-tax Income | -6,957 | -3,827 | -9,693 | -13,417 | -9,006 |
| Net Income Continuous | -6,957 | -3,827 | -9,693 | -13,417 | -9,006 |
| Net Income | $-6,957 | $-3,827 | $-9,693 | $-13,417 | $-9,006 |
| EPS Basic Total Ops | -0.58 | -0.42 | -1.37 | -1.86 | -1.34 |
| EPS Basic Continuous Ops | -0.58 | -0.42 | -1.37 | -1.86 | -1.34 |
| EPS Diluted Total Ops | -0.58 | -0.42 | -1.37 | -1.86 | -1.34 |
| EPS Diluted Continuous Ops | -0.58 | -0.42 | -1.37 | -1.86 | -1.34 |
| EBITDA(a) | $-6,141 | $-2,622 | $-7,169 | $-8,633 | $-6,851 |